Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer

European Journal of Endocrinology

Volumn 150, Issue 5, 2004, Pages 649-653

  Taylor, Henry ^a   Hyer, Stephen ^a,b   Vini, Louiza ^a   Pratt, Brenda ^a   Cook, Gary ^a   Harmer, Clive ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CENTER; CERVICAL LYMPH NODE; CLINICAL FEATURE; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RECURRENT DISEASE; RELIABILITY; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROIDECTOMY; TUMOR DIFFERENTIATION; WHOLE BODY SCINTISCANNING; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; THYROID TUMOR;

AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 2942711384     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500649     Document Type: Article

References (19)

1. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. Journal of Clinical Endocrinology and Metabolism 1992 75 714-720.
2. Schlumberger M. Papillary and follicular thyroid carcinoma. New England Journal of Medicine 1998 338 297-306.
3. Vini L & Harmer C. Radioiodinc treatment for differentiated thyroid cancer. Clinical Oncology 2000 12 365-372.
4. Spencer CA, LoPresti JS, Fatemi S & Nicoloff JT. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 1999 9 435-441.
5. Schlumberger M & Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. European Journal of Endocrinology 1998 138 249-252.
6. Schlumberger M, Ricard M & Pacini F. Clinical use of recombinant human TSH in thyroid cancer patients. European Journal of Endocrinology 2000 143 557-563.
7. Cailleux AF, Baudin E. Travagli JP, Ricard M & Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer. P Journal of Clinical Endocrinology and Metabolism 2000 85 175-178.
8. Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D & Pinchera A. Diagnostic 131-Iodine whole body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. Journal of Clinical Endocrinology and Metabolism 2002 87 1499-1501.
9. British Thyroid Association and Royal College of Physicians. Guidelines jbr the Management of Thyroid Cancer in Adults. Royal College of Physicians: London. 2002.
10. TNM Classification of Malignant Tumours. In AJCC Cancer Staging Manual 5th edn. Eds LH Sobin & CH Wittekind. New York: Wiley, 1997.
11. Grigsby PW, Baglan K & Siegal BA. Surveillance of patients to detect recurrent thyroid carcinoma. Cancer 1999 85 945-951.
12. Sherman SI, Tielens ET, Sostre S, Wharam MD & Ladenson PW. Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1994 78 629-634.
13. Reynolds JC. Percent 131I uptake and post-therapy 131I scans: their role in the management of thyroid cancer. Thyroid 1997 7 281-284.
14. Lees W, Mansberg R, Roberts J, Towson J, Chua E & Turtle J. The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I. European Journal of Nuclear Medicine 2002 29 1421-1427.
15. Mazzaferri EL & Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? Journal of Clinical Endocrinology and Metabolism 2002 87 1490-1498.
16. Mariotti S, Barbesino G, Caturegli P, Marino M, Manetti L, Parini F et al. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? Journal of Clinical Endocrinology and Metabolism 1995 80 468-472.
17. Westbury C, Vini L, Fisher C & Harmer C. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin. Thyroid 2000 10 171-176.
18. Torlontano M, Crocetti U, D'Aloiso L, Bonfitto N, Di Giogio A, Modoni S et al, Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. European Journal of Endocrinology 2003 148 19-24.
19. Britton KE & Foley RR. Should high Tg levels in the absence of iodine uptake be treated? European Journal of Nuclear Medicine and Molecular Imaging 2003 30 794-795.